Skip to Content

Seven Canyons Strategic Global Investor WASIX

Medalist Rating as of | See Seven Canyons Investment Hub
  • NAV / 1-Day Return 10.23  /  −0.78 %
  • Total Assets 20.4 Mil
  • Adj. Expense Ratio
    1.400%
  • Expense Ratio 1.400%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Global Small/Mid Stock
  • Investment Style Small Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 2.30%
  • Turnover 102%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 12:28 AM GMT+0

Morningstar’s Analysis WASIX

Will WASIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Seven Canyons Strategic Global Investor's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings WASIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 32.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Sirca Paints India Ltd Ordinary Shares

5.12 1.2 Mil
Basic Materials

LT Foods Ltd

3.67 838,794
Consumer Defensive

Kinx Inc

3.57 815,854
Communication Services

Arman Financial Services Ltd

3.50 800,412
Financial Services

State Street Instl US Govt MMkt Inv

3.45 790,337
Cash and Equivalents

Flatex AG

3.35 766,908
Financial Services

Riverstone Holdings Ltd

2.99 683,926
Healthcare

Corporativo Fragua SAB de CV Class B

2.72 621,283
Healthcare

Datamatics Global Services Ltd

2.68 613,004
Technology

Linical Co Ltd

2.35 538,645
Healthcare